An older adult client has been discharged following treatment for heart failure, and will be taking a loop diuretic. Which instructions from the nurse are appropriate? Select all that apply

Digoxin is a cardiac glycoside that exerts positive inotropic effects by inhibiting the Na+/K+-ATPase pump. This increases intracellular calcium, facilitating myocardial contraction in patients with congestive heart failure. Pharmacological dosing requires precise milligram-microgram conversions to avoid life-threatening digitalis toxicity. The therapeutic reference range is 0.5 to 2.0 ng/mL, and the drug is contraindicated in ventricular fibrillation or obstructive cardiomyopathy.

Rationale for correct answer

The nurse must first perform a metric conversion where 0.125 mg is multiplied by 1000.

This is equal to 125 mcg.

Using the standard formula, the desired dose of 125 mcg is divided by the available concentration of 50 mcg.

This calculation yields a volume of exactly 2.5 mL to be administered.

Test-taking strategy

• Identify the drug and units: The medication is digoxin, and the order is in mg, while the supply is in mcg.
• Convert to a common unit:
  • Always convert to the unit available on the label to simplify the final step.
  • 0.125 mg × 1000 = 125 mcg.
• Apply the dosage formula:
  • Use (Desired / Have) × Quantity.
  • (125 mcg / 50 mcg) × 1 mL = 2.5 mL.
• Verify the logic:
  • If 1 mL contains 50 mcg, then 2 mL contains 100 mcg.
  • The dose is 125 mcg, so the answer must be more than 2 mL but less than 3 mL.
  • 2.5 mL is the only mathematically logical result based on this estimation.
• Safety check: Digoxin has a narrow therapeutic index. Any calculated volume that seems unusually large (like 25 mL) should be immediately questioned.

Take home points

• Accurate conversion between milligrams and micrograms is the most critical step in calculating cardiac glycoside dosages.
• Standardized liquid concentrations of digoxin are often measured in micrograms to ensure high precision in dose delivery.
• Doubling-checking the decimal point placement is essential, as a single-place error can result in a ten-fold overdose.
• Always use a calibrated oral syringe for feeding tube administration to ensure the exact delivery of small-volume medications.

Digoxin is a cardiac glycoside that inhibits the sodium-potassium ATPase pump to increase intracellular calcium, facilitating positive inotropy. It manages heart failure and tachyarrhythmias, but its therapeutic window is narrow, ranging from 0.5 to 2.0 ng/mL. Toxicity risk is significantly amplified by hypokalemia, as low potassium increases drug binding to myocardial receptors. Severe toxicity can manifest as life-threatening ventricular dysrhythmias or heart block.

Rationale for correct answer

C. A serum potassium level of 2.0 mEq/L indicates severe hypokalemia, which dramatically sensitizes the myocardium to digoxin. Potassium and digoxin compete for the same binding site on the ATPase pump enzyme. When extracellular potassium is significantly low, more digoxin molecules bind to the pump, leading to excessive intracellular calcium and toxicity. This specific electrolyte imbalance is the most common cause of digitalis-induced arrhythmias in clinical practice.

Rationale for incorrect answers

A. An apical pulse rate of 62 beats/min is within the normal range for an adult at rest. While digoxin has negative chronotropic effects, the nurse typically only withholds the medication if the heart rate drops below 60 beats/min. This heart rate does not suggest drug accumulation or an increased risk of toxic manifestations. Continuous monitoring is required, but this finding is currently hemodynamically stable.

B. The serum digoxin level of 1.5 ng/mL is within the accepted therapeutic range of 0.5 to 2.0 ng/mL. This concentration suggests that the medication is providing necessary inotropic support without reaching toxic thresholds in the bloodstream. A level of 1.5 ng/mL is generally considered safe and effective for treating congestive heart failure.

D. A serum calcium level of 9.9 mEq/L is a normal finding, as the reference range is typically 9.0 to 10.5 mEq/L. Although hypercalcemia can potentiate the effects of digoxin and lead to toxicity, this value does not represent an elevation. The client is not at an increased risk of cardiac glycoside complications based on this stable electrolyte profile.

Test-taking strategy

• Identify the core objective: The question asks for a finding that increases the possibility of toxicity, not necessarily a symptom of toxicity itself.
• Compare lab values to standard reference ranges:
  • Potassium: 3.5 to 5.0 mEq/L (Choice 3 is significantly low).
  • Digoxin: 0.5 to 2.0 ng/mL (Choice 2 is normal).
  • Calcium: 9.0 to 10.5 mEq/L (Choice 4 is normal).
• Apply pharmacological principles: Recall that hypokalemia (low potassium) is the primary metabolic disturbance that triggers digoxin toxicity due to competitive binding at the cellular level.
• Analyze nursing assessment: An apical pulse of 62 (Choice 1) is above the standard hold parameter of 60, making it a normal finding.
• Use risk prioritization: When multiple choices involve electrolytes, select the one that has the most profound and direct impact on the medication's safety profile.
• Focus on preventative safety: Recognizing a low potassium level is a proactive nursing action to prevent toxicity before clinical symptoms emerge.

Take home points

• Hypokalemia significantly increases the risk of digoxin toxicity because potassium and digoxin compete for binding sites on the sodium-potassium ATPase pump.
• The therapeutic range for digoxin is narrow (0.5 to 2.0 ng/mL), necessitating frequent blood draws to ensure the patient remains within safe limits.
• Nurses must assess the apical pulse for 1 full minute before administration and withhold the dose if the heart rate is less than 60 beats/min.
• Other electrolyte imbalances that increase toxicity risk include hypomagnesemia and hypercalcemia, both of which can lead to life-threatening cardiac dysrhythmias.